Log in

Relevant bibliographies by topics / Antihelicobacter pyloli therapy

Contents

Journal articles

Academic literature on the topic 'Antihelicobacter pyloli therapy'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antihelicobacter pyloli therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antihelicobacter pyloli therapy"

1

Tomilina, T.V. "Антиоксидантное действие оральных аппликаций кверцетинсодержащих гелей у крыс, получавших антихеликобактерную терапию = Antioxidant effect of gels containing quercetin which were applied orally to rats treated with antihelicobacter pyloli therapy". Journal of Education, Health and Sport 5, № 2 (2015): 179–86. https://doi.org/10.5281/zenodo.15993.

Full text

Abstract:

<strong>Tomilina</strong> <strong>T</strong><strong>.</strong><strong>V</strong><strong>.</strong> <strong>Антиоксидантное действие оральных аппликаций кверцетинсодержащих гелей у крыс, получавших антихеликобактерную терапию </strong><strong>= Antioxidant effect of gels containing quercetin which were applied orally to rats treated with antihelicobacter pyloli therapy. Journal of Education, Health and Sport. </strong><strong>2015;5(2):179-186. </strong><strong>ISSN 2391-8306</strong><strong>. </strong><strong>DOI:</strong> <strong>10.5281/zenodo.15993</strong> <strong>http://ojs.ukw.edu.p

APA, Harvard, Vancouver, ISO, and other styles

2

Urazova, R. Z. "Treatment of inflammatory periodontal diseases in children infected with Helicobacter pylori." Kazan medical journal 82, no. 3 (2001): 208–9. http://dx.doi.org/10.17816/kazmj72140.

Full text

Abstract:

Microorganisms, including Helicobacter pylori, play an important role in the etiology of inflammatory periodontal diseases. The aim of our study was to study the effectiveness of topical use of metronidazole on the mucous membranes of the oral cavity in combination with antihelicobacter therapy for Helicobacter pylori infection in childhood.

APA, Harvard, Vancouver, ISO, and other styles

3

Shmatenko, O. P., та V. V. Osyodlo. "Рharmacoeconomic analysis of medical provision to servicemen with h. рylori associated chronic gastritis". Health of Society 9, № 5 (2021): 213–18. http://dx.doi.org/10.22141/2306-2436.9.5.2020.226950.

Full text

Abstract:

Baskground. The problem of treatment of chronic gastritis in servicemen, as one of the most common diseases of the gastrointestinal tract, is especially relevant in the light of the evidence on the determining role of H. pylori (HP)-infection in the progression of the disease and its complications pharmacoeconomically justified drug therapy regimens. The high level of resistance of H. pylori infection to antibiotics is one of the key factors influencing the effectiveness of antihelicobacter therapy. Studies conducted in the northern, eastern and western regions are devoted to the issue of HP a

APA, Harvard, Vancouver, ISO, and other styles

4

Paliy, I. G., S. V. Zaika, and N. M. Kondratiuk. "Eradication of Helicobacter pylori: what determines the effectiveness antihelicobacter pharmacotherapy (according to the results of the analysis of urease breath tests performed in 2006-2019 in Vinnytsia region)." Reports of Vinnytsia National Medical University 26, no. 2 (2022): 191–201. http://dx.doi.org/10.31393/reports-vnmedical-2022-26(2)-04.

Full text

Abstract:

Annotation. One of the global challenges of modern gastroenterology, which prevents the provision of acceptable levels of eradication of Helicobacter pylori, is the problem of increasing resistance of Helicobacter pylori to previously effective antibiotic regimens. The aim of the study – evaluate the effectiveness of Helicobacter pylori eradication depending on the chosen antihelicobacter pharmacotherapy regimen and the used proton pump inhibitors. We analyzed the results of 906 urea breath tests, which were conducted to monitor the effectiveness of antihelicobacter therapy for the period from

APA, Harvard, Vancouver, ISO, and other styles

5

Akkuratova, I. S., E. M. Spivak, and O. M. Manyakina. "Coinfection of gastric mucosa with Helicobacter Pylori and Epstein-Barr virus as a factor of ineffectiveness of antihelicobacter chronic gastritis therapy in adolescents." Perm Medical Journal 36, no. 1 (2019): 27–30. http://dx.doi.org/10.17816/pmj36127-30.

Full text

Abstract:

Aim. To assess the character of bacterial-viral infection of the gastric mucosa and dynamics of inflammatory process in adolescents with chronic gastritis in case of antihelicobacter therapy failure. Materials and methods. Seventy two adolescents with chronic gastritis aged 11–18 years (mean age 13.8 ± 0.4) were examined prior to and after antihelicobacter therapy. Results. It was established that after treatment against the background of regression of clinical symptoms, in most patients no positive dynamics of process manifestation or its progression was noted both in the body and

APA, Harvard, Vancouver, ISO, and other styles

6

Parkhomenko, V. V., І. М. Skrypnyk, І. І. Starchenko, and O. F. Gopko. "CHARACTERISTICS OF GASTRIC MUCOSA INJURY IN PATIENTS WITH NSAID-INDUCED GASTROPATHY AND CONCOMITANT ISCHEMIC HEART DISEASE, AND WAYS TO CORRECT THIS CONDITION." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 20, no. 2 (2020): 70–75. http://dx.doi.org/10.31718/2077-1096.20.2.70.

Full text

Abstract:

The non-steroidal anti-inflammatory drugs (NSAIDs) in general clinical practice can provoke the development of NSAID-induced gastropathy, which can be complicated by bleeding. The aim of this article was to evaluate the effect of eupatilin on histological changes of the gastric mucosa in patients with NSAID-induced gastropathy and concomitant ischemic heart disease depending on the association with Helicobacter pylori. The study included 125 patients with NSAID-gastropathy and concomitant stable ischemic heart disease I-II functional class. Patients were divided into two groups: I (n=82) inclu

APA, Harvard, Vancouver, ISO, and other styles

7

RIZAEV, Zhasur Alimdzhanovich, Lutfulla Saidullaevich MAKHMONOV, Abdugafar Gadaevich GADAEV, and Rustam Ismatullaevich TURAKULOV. "CHOICE OF THERAPY FOR IRON DEFICIENCY ANEMIA ASSOCIATED WITH HELICOBACTER PYLORI." Journal of biomedicine and practice 7, no. 5 (2022): 5. https://doi.org/10.5281/zenodo.7392766.

Full text

Abstract:

Aim: in a comparative aspect, to choose the most effective method for the treatment of iron deficiency anemia associated with Helicobacter pylori. Material and methods: The study was conducted in 90 patients diagnosed with iron deficiency anemia with complaints of the gastrointestinal tract, which were divided into two groups. The first group consisted of 60 patients who initially received antihelicobacter complex treatment (amoxiclav + clarithromycin + ezemeprozole), and then antianemic drugs (first by injection, and then in tablets for 3 months, depending on the severity of the disease). The

APA, Harvard, Vancouver, ISO, and other styles

8

Fadieienko, G. D., and Y. V. Nikiforova. "Maastricht VI/Florence Consensus for the treatment of Helicobacter pylori infection: updated recommendations for cancer prevention opportunities." Modern Gastroenterology, no. 2 (April 30, 2023): 14–25. http://dx.doi.org/10.30978/mg-2023-2-14.

Full text

Abstract:

For many decades, one of the most relevant issues remains the effectiveness of treatment of diseases associated with Helicobacter pylori (H. pylori) infection, the main goal of which is the prevention of gastric cancer (GC). The basic principles of diagnosis and treatment of helicobacter infection from the standpoint of evidence‑based medicine formulated in the Maastricht Consensus series. The data is constantly updated and refined by experts based on dynamic research. The new Maastricht VI/Florence Consensus clarified a number of provisions that were previously under discussion. One of the ma

APA, Harvard, Vancouver, ISO, and other styles

9

Baryshnikova, N. V., M. D. Lovchikova, and I. I. Shishlova. "Molecular-genetic studies in the diagnosis of Helicobacter pylori infection." Medical alphabet, no. 34 (January 23, 2025): 27–34. https://doi.org/10.33667/2078-5631-2024-34-27-34.

Full text

Abstract:

The issues of optimizing the management of patients infected with Helicobacter pylori have remained relevant in clinical therapy and gastroenterology for many years. This is due both to the high prevalence of H. pylori infection in Russia: depending on the region, it is 35–60 %, and to the potential carcinogenicity of the microorganism in relation to the development of stomach cancer. According to clinical recommendations, when conducting an endoscopic examination of the upper gastrointestinal tract, a rapid urease test with a biopsy from the antrum and the body of the stomach or polymerase ch

APA, Harvard, Vancouver, ISO, and other styles

10

Liakh, Olesya I., Mariya A. Derbak, Yelyzaveta S. Sirchak, Mariana I. Tovt-Korshуnska, and Yana V. Lazur. "ASSESSMENT OF THE IMPACT OF ANTIREFLUX THERAPY ON THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE." Wiadomości Lekarskie 74, no. 10 (2021): 2580–84. http://dx.doi.org/10.36740/wlek202110209.

Full text

Abstract:

The aim: To examine the effect of antireflux therapy on the course of COPD. Materials and methods: Under observation were 60 patients who were hospitalized in the «Transcarpathian Regional Clinical Hospital named after Andrei Novak» with a diagnosis of COPD II gr B in combination with GERD and 36 patients diagnosed with GERD who were treated on an outpatient basis. To study the effectiveness of antireflux therapy and its impact on the course of COPD, patients are divided into 2 groups: 1 group (main) (n = 60) – patients with COPD in combination with GERD, group 2 (control) (n = 36) – patients

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!